-
Diagnostic Panel Update
Optimized Diagnostic Panel for Metabolic Diseases incl. Mitochondriopathies based on the latest research insights
-
New Diagnostic Option: Whole Genome Diagnostics
A second-tier option for rare, unsolved genetic cases
-
New: Proteomics
Advanced proteomics services for biomarker discovery, protein analysis, and drug development
-
New Tumor Service: CancerIFP
Multiplex immunofluorescence staining for analyzing tumor microenvironment & signaling pathways
-
20% Price Drop on HiFi Whole Genome Sequencing
Highly accurate long-read data, paired with CeGaT's renowned service
-
What Is the Real Diagnostic Benefit of Whole-Genome Sequencing?
Read our newly released Scientific Note
-
RPS Insights
Interesting and exciting content and topics related to Research & Pharma Solutions
-
Genetic Diagnostics
Find the genetic causes of rare diseases
-
Research & Pharma Solutions
Sequencing Services and Pharma Solutions - Made in Germany
-
Update of our
Diagnostic Panel Metabolic Diseases incl. Mitochondriopathies -
New Diagnostic Option:
Whole Genome Diagnostics -
New: Proteomics
-
New Tumor Service:
CancerIFP -
20% on HiFi Whole Genome Sequencing
-
Newly released
Scientific Note -
New: RPS Insights
-
Genetic
Diagnostics -
Research &
Pharma Solutions
Genetic Insights You Can Trust
Since 2009, we have been helping doctors and patients find the genetic causes of rare diseases. We help oncologists and cancer patients find the best therapy option. We continue to drive science forward with our own insights. We provide scientists and pharmaceutical companies with sequencing services for clinical trials and their research. Next-generation sequencing is our core technology which we make available in a high-throughput format. To ensure our high-quality standards, we are accredited according to CAP/CLIA, DIN EN ISO 15189, DIN EN ISO/IEC 17025, and our services are IVDR compliant (IVDR 2017/746).
Our News
Get the genetic analyses of tomorrow today. We transform our extensive knowledge and the latest scientific findings into real-life and practical applications for medicine and research and continuously evolve our services.



